Clinical technology group Sensyne Health said it planned to developer a software application for people with diabetes. Its intended user population would cover all stages of the disease, including individuals at risk of developing diabetes, as well as those with a diagnosis of pre-diabetes, type 1 or type 2. The product would be designed to connect people with diabetes with the clinician responsible for their care. A related app would provide their clinician with information on the status of the patient and whether any intervention may be required. Initial clinical use would be undertaken by three NHS Trusts over the coming months to evaluate health-economic and operational benefits. Sensyne Health said it planned to launch in the US towards the end of the current financial year.
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.